Correlates of toxicity in metastatic melanoma patients treated with ipilimumab.

被引：0
|
作者：
Valpione, Sara
Pigozzo, Jacopo
Pasquali, Sandro
Piccin, Luisa
Mocellin, Simone
Campana, Luca Giovanni
Chiarion-Sileni, Vanna
机构：
[1] Univ Padua, Padua, Italy
[2] Ist Oncol Veneto IRCCS, Padua, Italy
[3] Univ Naples Federico II, Padua, Italy
[4] Univ Padua, Dept Oncol & Surg Sci, Padua, Italy
[5] Veneto Oncol Inst, Padua, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e21010
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21010
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The impact of body composition parameters on ipilimumab toxicity and survival in patients with metastatic melanoma
    Daly, Louise E.
    Power, Derek G.
    O'Reilly, Aine
    Donnellan, Paul
    Cushen, Samantha J.
    O'Sullivan, Kathleen
    Twomey, Maria
    Woodlock, David P.
    Redmond, Henry P.
    Ryan, Aoife M.
    BRITISH JOURNAL OF CANCER, 2017, 116 (03) : 310 - 317
  • [22] The full blood count as a biomarker of outcome and toxicity in ipilimumab-treated cutaneous metastatic melanoma
    Khoja, Leila
    Atenafu, Eshetu G.
    Templeton, Arnoud
    Qye, Ye
    Chappell, Mary Anne
    Saibil, Sam
    Hogg, David
    Butler, Marcus O.
    Joshua, Anthony M.
    CANCER MEDICINE, 2016, 5 (10): : 2792 - 2799
  • [23] Enterocolitis in a Patient Being Treated With Ipilimumab for Metastatic Melanoma
    Koch, Christine
    Paetzold, Sylvie
    Trojan, Joerg
    GASTROENTEROLOGY, 2012, 143 (02) : 298 - 505
  • [24] Panhypopituitarism in metastatic melanoma patient treated with ipilimumab and pembrolizumab
    Goto, Haruka
    Kasuya, Akira
    Imura, Kie
    Miyazawa, Hidehiko
    Fujiyama, Toshiharu
    Kakizawa, Keisuke
    Tokura, Yoshiki
    JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2019, 2 (02) : 60 - 61
  • [25] Prevalence of hypophysitis in a cohort of patients with metastatic melanoma and prostate cancer treated with ipilimumab
    Lucia Brilli
    Riccardo Danielli
    Cristina Ciuoli
    Luana Calabrò
    Anna Maria Di Giacomo
    Alfonso Cerase
    Patrizia Paffetti
    Fausta Sestini
    Brunetta Porcelli
    Michele Maio
    Furio Pacini
    Endocrine, 2017, 58 : 535 - 541
  • [26] Prevalence of hypophysitis in a cohort of patients with metastatic melanoma and prostate cancer treated with ipilimumab
    Brilli, Lucia
    Danielli, Riccardo
    Ciuoli, Cristina
    Calabro, Luana
    Di Giacomo, Anna Maria
    Cerase, Alfonso
    Paffetti, Patrizia
    Sestini, Fausta
    Porcelli, Brunetta
    Maio, Michele
    Pacini, Furio
    ENDOCRINE, 2017, 58 (03) : 535 - 541
  • [27] Peripheral and tumor immune correlates in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab.
    Callahan, Margaret K.
    Horak, Christine E.
    Curran, Michael A.
    Hollman, Travis
    Schaer, David A.
    Yuan, Jianda
    Lesokhin, Alexander M.
    Kitano, Shigehisa
    Hong, Quan
    Ariyan, Charlotte Eielson
    Busam, Klaus J.
    Feely, William
    Jure-Kunkel, Maria
    Grosso, Joseph
    Simon, Jason S.
    Korman, Alan J.
    Wigginton, Jon M.
    Gupta, Ashok Kumar
    Sznol, Mario
    Wolchok, Jedd D.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [28] Evaluation of a Multidisciplinary Immunotherapy Toxicity Monitoring Program for Patients Receiving Ipilimumab for Metastatic Melanoma
    Menjak, Ines B.
    Elias, Evelyn S.
    Jain, Sheena
    Lawrie, Deborah
    Petrella, Teresa M.
    JCO ONCOLOGY PRACTICE, 2021, 17 (11) : 673 - +
  • [29] Efficacy and toxicity of Ipilimumab-Nivolumab combination therapy in elderly metastatic melanoma patients
    Stoff, Ronen
    Grynberg, Shirly
    Asher, Nethanel
    Laks, Shachar
    Steinberg, Yael
    Schachter, Jacob
    Shapira-Frommer, Ronnie
    Ben-Betzalel, Guy
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [30] Toxicity and response to ipilimumab and nivolumab in older patients with metastatic melanoma: A multicentre retrospective analysis
    Pathmanathan, Shivanshan
    Babu, Hari
    Dzienis, Marcin
    Azer, Mary
    Eastgate, Melissa
    PIGMENT CELL & MELANOMA RESEARCH, 2022, 35 (06) : 587 - 594
12345